Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05504811 · ClinicalTrials.gov registry record · NA
FitMi AD Home Therapy for Individuals With MCI or Mild Dementia Due to Alzheimer's Disease
A NA study, sponsored by Flint Rehabilitation Devices.
- Completed
- Registry status
- NA
- Development phase
- 31
- Enrollment target
NCT05504811: Completed NA study, sponsored by Flint Rehabilitation Devices.
NCT05504811 is a NA study that has completed, run by Flint Rehabilitation Devices. The registered enrollment target is 31 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05504811, a NA study, has completed, sponsored by Flint Rehabilitation Devices.
- COMPLETED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
Study Summary
This study will investigate the efficacy of a newly developed exercise device (FitMi AD) for individuals with mild cognitive impairment (MCI) or mild dementia due to Alzheimer's disease. FitMi AD uses embedded sensors that can track and record the patient's direction and degree of movement while performing exercises described on a computer.
Primary Outcome
How far can someone reach while standing in a fixed position
Interventions
- DEVICE FitMi AD
- OTHER Conventional exercise program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2023-09-08 |
| Est. Completion | 2025-03-12 |
| Phase | NA |
What the finished NCT05504811 record still lists
NCT05504811 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 31 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which FitMi AD is the first listed.
NCT05504811 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05504811 about?
NCT05504811 is a clinical study titled "FitMi AD Home Therapy for Individuals With MCI or Mild Dementia Due to Alzheimer's Disease". This study will investigate the efficacy of a newly developed exercise device (FitMi AD) for individuals with mild cognitive impairment (MCI) or mild dementia due to Alzheimer's disease. FitMi AD uses embedded sensors that can track and record the patient's direction and degree of movement while per...
What is the current status of trial NCT05504811?
This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2023-09-08. Estimated completion is 2025-03-12.
What interventions are being tested in trial NCT05504811?
The interventions under investigation include: FitMi AD (DEVICE), Conventional exercise program (OTHER).
Who is sponsoring clinical trial NCT05504811?
This trial is sponsored by Flint Rehabilitation Devices, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05504811's enrollment target sits among peer trials
31 1592nd of 2000 higher than 408 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02932618 · 31 participants · Phase 3
A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)
- NCT03482297 · 31 participants · Phase 1
Automated Abdominal Binder for Orthostatic Hypotension
- NCT04016389 · 31 participants · NA
FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery
- NCT04211675 · 31 participants · Phase 1
NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI